Occasional acute and chronic conjunctivitis with various etiologies and moderate severity.
Composition:
1 ml of solution contains 1 mg of naphazoline nitrate and 2.5 mg of zinc sulfate. The preparation contains benzalkonium chloride.
Action:
Zinc sulphate, applied topically, has astringent, anti-inflammatory and weakly antiseptic effect. Naphazoline stimulates vascular α-adrenergic receptors and applied topically constricts the conjunctiva blood vessels. The combined effect of two substances with different mechanisms of action leads to the elimination of symptoms associated with inflammation. The effect of nafazoline appears 5 min after topical administration and lasts for 6-8 hours.
Contraindications:
Hypersensitivity to the components of the preparation or adrenomimetric drugs. Glaucoma with a narrow angle. Dry eye syndrome. Hypertension. Hyperthyroidism. Children under 2 years.
Precautions:
Long-term use leads to damage to the epithelium of the eye. Misuse of drops in children and elderly patients can cause systemic side effects of nafazoline. Due to the content of benzalkonium chloride in the preparation, people wearing soft (hydrophilic) contact lenses should remove them before instillation and wait at least 15 minutes. before re-installation. Benzalkonium chloride may cause eye irritation and change the color of contact lenses.
Pregnancy and lactation:
The preparation can be used during pregnancy only if the benefit for the mother outweighs the potential risk to the fetus. Use with caution when breastfeeding.
Side effects:
Transient hyperemia and conjunctival irritation may occur. Rarely: drowsiness, dizziness, headache, nausea, weakness, blurred vision, nervousness, excessive perspiration.
Dosage:
Topically 1 drop into the conjunctival sac of the eye (eyes) 4 times a day. The drug should not be used for more than 3-5 days. The patient should be advised not to touch the tip of the dropper, as this may contaminate the contents of the bottle.
(C)
